Completed
Repetitive GON Blockade for Menstrual Migraine
Perimenstrual Repetitive Greater Occipital Nerve Blockade for Menstrual Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial
- Status
- Completed
- Registry ID
- NCT07576309
- Type
- Interventional (tests a treatment)
- Phase
- NA
- Conditions
- Menstrual Migraine, Menstrually Related Migraine
- What is tested
- 0.5% bupivacaine (drug); Normal Saline (other)
- Sponsor
- Saglik Bilimleri Universitesi
- Where
- Turkey (Türkiye)
- Participants
- 48
- Start
- 2024-10-19
- Completion
- 2025-11-30
- Last update
- 2026-05-08
About the study
: The primary objective of this prospective, randomized, double-blind, placebo-controlled clinical trial is to evaluate whether repetitive bilateral greater occipital nerve (GON) blockade administered with a local anesthetic (0.5% bupivacaine) significantly reduces headache severity, attack duration, and the number of pain days in female patients with menstrual migraine compared to a placebo group (normal saline). Patients will receive injections twice a month for three months (seven days before the expected onset of menstruation and on the first day of menstruation).
Summary from ClinicalTrials.gov.